Exploring Drug Repurposing for Interstitial Cystitis/Bladder Pain Syndrome: Defining Novel Therapeutic Targets
Bioinformatics can be useful for identifying therapeutic agents for IC/BPS by accessing and processing big data on molecular and cellular levels. Prospective in vivo experiments must validate repurposed drugs. The expansion of large-scale genome sequencing, gene expression studies, and clinical data for IC/BPS will improve successful drug selection.
Authors
- Zeliha Görmez (ORCID: https://orcid.org/0000-0001-9519-2647)
- Güldal İnal Gültekin (ORCID: https://orcid.org/0000-0002-8313-6119)
- Naşide Mangır (ORCID: https://orcid.org/0000-0002-3062-6480)
Institutions
- TH Bingen University of Applied Sciences (DE)
- Hacettepe University (TR)
- Okan University (TR)
Publication Details
- Journal
- Neurourology and Urodynamics
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1002/nau.25651
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00